Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults [Phase 1]
A Phase 1 clinical trial to detect the radioactivity of the radiolabeled compound SEP-380135 (14C) in urine and feces in healthy male adults…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Feasibility, Acceptability, and Effectiveness of a Hatha Yoga-in Patients Hospitalized for Schizophrenia [NA]
A clinical trial is evaluating the feasibility, acceptability, and effectiveness of Hatha Yoga for hospitalized adults with schizophrenia.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression [NA]
This ongoing clinical trial explores whether virtual reality eye tracking can help identify schizophrenia, bipolar disorder, and major depre…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.
This ClinicalTrials.gov update describes a study examining how prior viral infections influence susceptibility and resilience to mental illn…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Novel Blood Test as a Biomarker in Mental Health
This clinical trial investigates a novel blood test biomarker for mental health conditions. The study (NCT06856161) is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-03-05FDA Approved: OLANZAPINE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved Glenmark's original application for a generic olanzapine product.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications [NA]
A clinical trial exploring brain network mechanisms underlying cognitive impairments across schizophrenia, bipolar disorder, and major depre…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Technology-Assisted Implementation of a Mobile Health Program for Serious Mental Illness [NA]
This entry reports a completed clinical trial from the University of Washington evaluating technology-assisted implementation of a mobile he…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Predictive Validity of the Personal and Social Performance Scale for PANSS Outcomes in Schizophrenia [Phase 2]
Phase 2 study evaluating whether the Personal and Social Performance Scale can predict PANSS outcomes in schizophrenia. The trial has been c…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders [NA]
This clinical trial update evaluates the acceptability, feasibility, and preliminary outcomes of the Kiso Mind app for outpatients with schi…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of Xanomeline/Trospium (XT) for cognitive impairment in adults with schizophrenia; recruitm…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Perception and Integration of Sensory Information in the Early Stages of Psychosis [NA]
A clinical trial update for a study on perception and integration of sensory information in the early stages of psychosis; sponsorship by Ce…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Medication Adherence in Severe Mental Illness: a Promotion Program [NA]
This document announces a clinical trial focused on promoting medication adherence in severe mental illness, including bipolar disorder and …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia [NA]
A clinical trial comparing accelerated intermittent theta burst stimulation vs high-frequency rTMS for cognitive symptoms in treatment-resis…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: The Hi-tACS on Cognitive Function in Patients With Schizophrenia [NA]
A clinical trial update announcing ongoing recruitment for Hi-tACS to assess cognitive function in patients with schizophrenia.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients [NA]
A clinical trial from The Hong Kong Polytechnic University is studying how smoking affects brain network connectivity in individuals with sc…
-
EMA approval · 2026-02-27EMA Authorised: Zyprexa (olanzapine) — CHEPLAPHARM Registration GmbH
The EMA authorised Zyprexa (olanzapine) for schizophrenia and bipolar disorder under CHEPLAPHARM Registration GmbH as the marketing authoris…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies [NA]
The CBTpro trial, scaling up CBT for psychosis using simulated patients and spoken language technologies, has completed and posted results. …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study [NA]
A completed pilot trial evaluated Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) for individuals with early psyc…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Theta- and Alpha-Tuned Meditation for Negative Symptoms in Schizophrenia [NA]
A completed clinical trial investigating theta- and alpha-tuned meditation for negative symptoms in schizophrenia.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques [NA]
A clinical trial to develop a novel occupational training program for schizophrenia patients based on virtual reality, currently recruiting …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings [NA]
This completed clinical trial compares two behavioral approaches to quitting smoking in individuals with tobacco use disorder and mental hea…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Brain Stimulation to the Hippocampus in Schizophrenia [NA]
The document reports an ongoing Stanford University clinical trial investigating brain stimulation to the hippocampus as a treatment for sch…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Enhanced Coordinated Specialty Care for Early Psychosis [NA]
Clinical trial update indicating recruitment for Enhanced Coordinated Specialty Care for early psychosis at McLean Hospital.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis [NA]
This clinical trial is evaluating normobaric oxygen therapy for individuals with first-episode psychosis, with recruitment ongoing.